Skip to main content
. 2022 Jul 22;2022:3850674. doi: 10.1155/2022/3850674

Table 2.

Clinical features of the subjects in GSE99573 dataset.

Features Normal (n, %) Adenoma (n, %) CRC (n, %)
Gender (n, %)
 Male 66 (33.85%) 59 (30.26%) 70 (35.90%)
 Female 45 (33.33%) 43 (31.85%) 47 (34.81%)

Age (n, %)
 <50 24 (35.29%) 31 (45.59%) 13 (19.12%)
 ≥50 87 (33.21%) 71 (27.10%) 104 (39.69%)

AJCC stage (n, %)
 Stage I 30 (25.64%)
 Stage II 25 (21.37%)
 Stage III 33 (28.21%)
 Stage IV 29 (24.79%)
 Total (n, %) 111 (100%) 102 (100%) 117 (100.00%)